Allianz Asset Management
TRIB

Allianz Asset Management’s Trinity Biotech TRIB Stock Holding History

Allianz Asset Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-34,901
Closed -$2.31M – 2675
2016
Q3 		$2.31M Sell
34,901
-976
-3% -$60.8K ﹤0.01% 1939
2016
Q2 		$2.03M Sell
35,877
-1,760
-5% -$99.2K ﹤0.01% 1912
2016
Q1 		$2.19M Sell
37,637
-1,032
-3% -$54.8K ﹤0.01% 1767
2015
Q4 		$2.27M Sell
38,669
-6,005
-13% -$354K ﹤0.01% 1662
2015
Q3 		$2.56M Buy
44,674
+451
+1% +$36.3K ﹤0.01% 1517
2015
Q2 		$3.99M Sell
44,223
-624
-1% -$54K ﹤0.01% 1453
2015
Q1 		$4.32M Sell
44,847
-5,108
-10% -$472K ﹤0.01% 1267
2014
Q4 		$4.37M Sell
49,955
-769
-2% -$66.3K ﹤0.01% 1262
2014
Q3 		$4.63M Sell
50,724
-4,545
-8% -$492K 0.01% 1096
2014
Q2 		$6.36M Sell
55,269
-1,697
-3% -$201K 0.01% 860
2014
Q1 		$6.9M Buy
56,966
+2,551
+5% +$334K 0.01% 861
2013
Q4 		$6.84M Buy
54,415
+2,911
+6% +$349K 0.01% 854
2013
Q3 		$5.6M Buy
51,504
+9,906
+24% +$966K 0.01% 885
2013
Q2 		$3.5M Buy
+41,598
New +$3.45M 0.01% 1014

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Allianz Asset Management's TRIB Position: Q4 2016 in Review

Allianz Asset Management sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 34,901 shares — an estimated $2.31M sold.

Allianz Asset Management first reported a position in TRIB in Q2 2013 and held it in 14 quarters. The position peaked at $6.9M in Q1 2014. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • Allianz Asset Management reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • Allianz Asset Management sold 34,901 Trinity Biotech shares in Q4 2016, an estimated $2.31M.
  • Allianz Asset Management first reported a position in Trinity Biotech in Q2 2013 and held it in 14 quarters.
  • Allianz Asset Management's Trinity Biotech position peaked at $6.9M in Q1 2014.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on Allianz Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.